Ergocalciferol and Avapro drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Ergocalciferol (ergocalciferol) and Avapro (irbesartan). Common drug interactions include influenza among females and anxiety among males.
The phase IV clinical study analyzes what interactions people have when they take Ergocalciferol and Avapro. It is created by eHealthMe based on reports of 179 people who take the same drugs from the FDA, and is updated regularly.
What is Ergocalciferol?
Ergocalciferol has active ingredients of ergocalciferol. It is often used in rickets. eHealthMe is studying from 32,652 Ergocalciferol users. Check the latest studies of Ergocalciferol.
What is Avapro?
Avapro has active ingredients of irbesartan. It is often used in high blood pressure. eHealthMe is studying from 19,840 Avapro users. Check the latest studies of Avapro.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
179 people who take Ergocalciferol and Avapro together, and have interactions are studied.
What are the common drug interactions of Ergocalciferol and Avapro, by gender? *
What are the common drug interactions of Ergocalciferol and Avapro, by age (0-1 to 60+)? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Ergocalciferol and Avapro?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Ergocalciferol (32,652 reports)
- Avapro (19,840 reports)
Browse all drug interactions of Ergocalciferol and Avapro:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Ergocalciferol:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Avapro:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Ergocalciferol and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Avapro and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Kapoor S, "Influence of Vitamin D Consumption and Levels on the Development of Psychiatric Disorders", Lee, Y. J., & Park, K. (2018). Secondary Raynaud’s Phenomenon and Skin Necrosis of Toes in the Paraplegic Patient with Hypertension.?Drug safety-case reports,?5(1), 7., 2014 Aug .
- Kapoor S, "Influence of Vitamin D Consumption and Levels on the Development of Psychiatric Disorders", Lee, Y. J., & Park, K. (2018). Secondary Raynaud’s Phenomenon and Skin Necrosis of Toes in the Paraplegic Patient with Hypertension.?Drug safety-case reports,?5(1), 7., 2014 Aug .
How the study uses the data?
The study uses data from the FDA. It is based on ergocalciferol and irbesartan (the active ingredients of Ergocalciferol and Avapro, respectively), and Ergocalciferol and Avapro (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Nicotinamide and Furosemide - a second ago
- Zide vs. Aldomet, side effect and effectiveness comparison - 18 seconds ago
- Could Amoxil cause Epicondylitis? - 20 seconds ago
- Could Evista cause Multiple Injuries? - 22 seconds ago
- Labetalol Hydrocloride vs. Valturna, side effect and effectiveness comparison - 23 seconds ago
- Could Emla cause Rhonchi? - 33 seconds ago
- Heart Attack and Appetite Decreased - 34 seconds ago
- Could Oxycodone And Acetaminophen cause Radiculopathy? - 34 seconds ago
- Heart Attack and Appetite - Decreased - 35 seconds ago
- Could Remicade cause Lung Squamous Cell Carcinoma Stage Unspecified? - 37 seconds ago